Literature DB >> 12019185

Immunohistochemical localization and activity of glutathione transferase zeta (GSTZ1-1) in rat tissues.

Hoffman B M Lantum1, Raymond B Baggs, Daria M Krenitsky, Philip G Board, M W Anders.   

Abstract

Glutathione transferase zeta (GSTZ1-1) catalyzes the biotransformation of a range of alpha-haloacids, including dichloroacetic acid (DCA), and the penultimate step in the tyrosine degradation pathway. DCA is a rodent carcinogen and a common drinking water contaminant. DCA also causes multiorgan toxicity in rodents and dogs. The objective of this study was to determine the expression and activities of GSTZ1-1 in rat tissues with maleylacetone and chlorofluoroacetic acid as substrates. GSTZ1-1 protein was detected in most tissues by immunoblot analysis after immunoprecipitation of GSTZ1-1 and by immunohistochemical analysis; intense staining was observed in the liver, testis, and prostate; moderate staining was observed in the brain, heart, pancreatic islets, adrenal medulla, and the epithelial lining of the gastrointestinal tract, airways, and bladder; and sparse staining was observed in the renal juxtaglomerular regions, skeletal muscle, and peripheral nerve tissue. These patterns of expression corresponded to GSTZ1-1 activities in the different tissues with maleylacetone and chlorofluoroacetic acid as substrates. Specific activities ranged from 258 +/- 17 (liver) to 1.1 +/- 0.4 (muscle) nmol/min/mg of protein with maleylacetone as substrate and from 4.6 +/- 0.89 (liver) to 0.09 +/- 0.01 (kidney) nmol/min/mg of protein with chlorofluoroacetic acid as substrate. Rats given DCA had reduced amounts of immunoreactive GSTZ1-1 protein and activities of GSTZ1-1 in most tissues, especially in the liver. These findings indicate that the DCA-induced inactivation of GSTZ1-1 in different tissues may result in multiorgan disorders that may be associated with perturbed tyrosine metabolism.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12019185     DOI: 10.1124/dmd.30.6.616

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  10 in total

1.  Age-Related Changes in Expression and Activity of Human Hepatic Mitochondrial Glutathione Transferase Zeta1.

Authors:  Guo Zhong; Margaret O James; Marci G Smeltz; Stephan C Jahn; Taimour Langaee; Pippa Simpson; Peter W Stacpoole
Journal:  Drug Metab Dispos       Date:  2018-05-31       Impact factor: 3.922

2.  Regulation of dichloroacetate biotransformation in rat liver and extrahepatic tissues by GSTZ1 expression and chloride concentration.

Authors:  Stephan C Jahn; Marci G Smeltz; Zhiwei Hu; Laura Rowland-Faux; Guo Zhong; Ryan J Lorenzo; Katherine V Cisneros; Peter W Stacpoole; Margaret O James
Journal:  Biochem Pharmacol       Date:  2018-04-05       Impact factor: 5.858

Review 3.  Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1.

Authors:  Margaret O James; Stephan C Jahn; Guo Zhong; Marci G Smeltz; Zhiwei Hu; Peter W Stacpoole
Journal:  Pharmacol Ther       Date:  2016-10-19       Impact factor: 12.310

4.  Mitochondrion as a novel site of dichloroacetate biotransformation by glutathione transferase zeta 1.

Authors:  Wenjun Li; Margaret O James; Sarah C McKenzie; Nigel A Calcutt; Chen Liu; Peter W Stacpoole
Journal:  J Pharmacol Exp Ther       Date:  2010-09-30       Impact factor: 4.030

5.  Prenatal and postnatal expression of glutathione transferase ζ 1 in human liver and the roles of haplotype and subject age in determining activity with dichloroacetate.

Authors:  Wenjun Li; Yuan Gu; Margaret O James; Ronald N Hines; Pippa Simpson; Taimour Langaee; Peter W Stacpoole
Journal:  Drug Metab Dispos       Date:  2011-10-25       Impact factor: 3.922

6.  Sperm Redox System Equilibrium: Implications for Fertilization and Male Fertility.

Authors:  Lauren E Hamilton; Richard Oko; Antonio Miranda-Vizuete; Peter Sutovsky
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases.

Authors:  Cindy E L Lim; Klaus I Matthaei; Anneke C Blackburn; Richard P Davis; Jane E Dahlstrom; Mark E Koina; M W Anders; Philip G Board
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

8.  Effects of Multiple Doses of Dichloroacetate on GSTZ1 Expression and Activity in Liver and Extrahepatic Tissues of Young and Adult Rats.

Authors:  Edwin J Squirewell; Marci G Smeltz; Laura Rowland-Faux; Lloyd P Horne; Peter W Stacpoole; Margaret O James
Journal:  Drug Metab Dispos       Date:  2020-09-01       Impact factor: 3.922

Review 9.  Pharmacogenetic considerations with dichloroacetate dosing.

Authors:  Margaret O James; Peter W Stacpoole
Journal:  Pharmacogenomics       Date:  2016-05-04       Impact factor: 2.533

10.  Physiologically based pharmacokinetic modeling of dibromoacetic acid in F344 rats.

Authors:  Jessica L Matthews; Irvin R Schultz; Michael R Easterling; Ronald L Melnick
Journal:  Toxicol Appl Pharmacol       Date:  2010-01-04       Impact factor: 4.219

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.